EGFR and neoplasm: Cytological samples, such as fine-needle aspirates, bronchial brushings, serum, plasma, circulating tumour cells and pleural effusion samples have all been used for EGFR mutation testing, but are considered less reliable because of heterogeneity of tissue samples and sparse cellularity [28].